Abstract
Ethanol (alcohol) consumption can modify immune responses. Moderate ethanol use is associated with lower production of mediators of inflammation and has anti-inflammatory effect, while ethanol abuse and alcoholism are linked with augmentation of inflammatory responses. Ethanol exposure can result in functional alterations of macrophages and other cells of the innate immune system. These cells recognize microbial antigens through Toll-like receptors (TLRs). Molecular mechanisms underlying the inflammatory responses stimulated via TLRs involve activation of intracellular signaling pathways that include mitogen-activated protein kinases (MAPKs) and transcription factor NFκB. Growing evidence indicates that ethanol can affect these cellular events in a manner that depends on the organ or cell type and the pattern of ethanol administration (moderate or acute versus chronic).
Keywords: Ethanol, inflammation, cardiovascular disease, cytokines, toll-like receptors, MAPK
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Ethanol and Inflammation
Volume: 6 Issue: 4
Author(s): Joanna Goral
Affiliation:
Keywords: Ethanol, inflammation, cardiovascular disease, cytokines, toll-like receptors, MAPK
Abstract: Ethanol (alcohol) consumption can modify immune responses. Moderate ethanol use is associated with lower production of mediators of inflammation and has anti-inflammatory effect, while ethanol abuse and alcoholism are linked with augmentation of inflammatory responses. Ethanol exposure can result in functional alterations of macrophages and other cells of the innate immune system. These cells recognize microbial antigens through Toll-like receptors (TLRs). Molecular mechanisms underlying the inflammatory responses stimulated via TLRs involve activation of intracellular signaling pathways that include mitogen-activated protein kinases (MAPKs) and transcription factor NFκB. Growing evidence indicates that ethanol can affect these cellular events in a manner that depends on the organ or cell type and the pattern of ethanol administration (moderate or acute versus chronic).
Export Options
About this article
Cite this article as:
Goral Joanna, Ethanol and Inflammation, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2007; 6 (4) . https://dx.doi.org/10.2174/187152307783219970
DOI https://dx.doi.org/10.2174/187152307783219970 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
microRNA Regulation as a Therapeutic Strategy for Cardiovascular Disease
Current Drug Targets Radionuclide PET and PET/CT in Coronary Artery Disease
Current Pharmaceutical Design Evaluation of Left Ventricular Volumes and Ejection Fraction from Gated Myocardial Perfusion SPECT Processed with “Myovation Evolution”: Comparison of Three Automated Software Packages using Cardiac Magnetic Resonance as Reference
Current Radiopharmaceuticals The Clinical Utility of Ambulatory Blood Pressure Monitoring (ABPM): A Review
Current Hypertension Reviews Renal Innervation in Resistant Hypertension: A Review of Pathophysiology and Renal Denervation as Potential Treatment
Current Hypertension Reviews Novel Carriers for Coenzyme Q10 Delivery
Current Drug Delivery Statin Treatment and the Natural History of Atherosclerotic-Related Diseases: Pathogenic Mechanisms and the Risk-Benefit Profile
Current Pharmaceutical Design An Insight into the Recent Diabetes Trials: What is the Best Approach to Prevent Macrovascular and Microvascular Complications?
Current Diabetes Reviews Effect of Rosuvastatin on Non-alcoholic Steatohepatitis in Patients with Metabolic Syndrome and Hypercholesterolaemia: A Preliminary Report
Current Vascular Pharmacology Frequencies of Single Nucleotide Polymorphisms in Cytochrome P450 Genes (CYP1A2, 2A6, 2B6, 3A4 and 3A5) in a Rwandan Population: Difference to Other African Populations
Current Pharmacogenomics and Personalized Medicine 24-Hour Blood Pressure Control – A Predictor for Clinical Outcomes
Current Hypertension Reviews Potential Options to Treat Hypertriglyceridaemia
Current Drug Targets From CHD Susceptibility Genes to New Therapeutics
Current Pharmacogenomics Medical and Dental Implications of Down Syndrome: A Review Part 1: General and Craniofacial Characteristic
Applied Clinical Research, Clinical Trials and Regulatory Affairs Skeletal Muscle Derived Stem Cells for Myocardial Repair
Recent Patents on Cardiovascular Drug Discovery Getting to the Heart of the Matter: Exploring Opportunities for Gene Therapy Treatment of Dystrophic Cardiomyopathy
Current Gene Therapy Is the Deficiency of Vitamin B12 Related to Oxidative Stress and Neurotoxicity in Parkinsons Patients?
CNS & Neurological Disorders - Drug Targets Increased Risk of Dementia in Patients with Non-Apnea Sleep Disorder
Current Alzheimer Research Optimal Management of Hypertension in patients with Ischemic Heart Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Patented Small Molecules Used for Reprogramming
Recent Patents on Regenerative Medicine